glp-1 obesity drug news updates A network meta-analysis backed weight-loss benefits with several receptor agonists, with less certainty for newer-generation agents. Read more at the link in bio GLP-1 Agonists Weight Loss Drugs

Rights and permissions About this article Cite this article Seminotti, B., Roginski, A.C., Zanatta,

Researchers have observed it helping torn Achilles tendons heal and broken bones mend more effectively in rats

Their primary mechanisms of action include: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps lower blood sugar levels with a low risk of hypoglycaemia when used alone (though risk increases when combined with insulin or sulfonylureas) Suppressing glucagon release from pancreatic alpha cells, reducing hepatic glucose production Slowing gastric emptying , which prolongs the feeling of fullness after meals Acting on appetite centres in the brain , particularly the hypothalamus, to reduce hunger and food intake These combined effects result in improved glycaemic control for people with diabetes and significant weight loss

Certain medical conditions and surgeries can hinder the bodys ability to produce it, leading to an increased risk of vitamin B12 deficiency